J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pagani, F.
Right arrow Articles by Baralle, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pagani, F.
Right arrow Articles by Baralle, F. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Journal of Lipid Research, Vol. 39, 1382-1388, July 1998
Copyright © 1998 by Lipid Research, Inc.


Original Article

New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease

Franco Pagania, Rajalakshmi Pariyaratha, Rodolfo Garciaa, Cristiana Stuania, Alberto B. Burlinab, Giacomo Ruotoloc, Marco Rabusind, and Francisco E. Barallea
a International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34012 Trieste, Italy
b Department of Pediatrics, University of Padova, via Giustiniani 3, 35128 Padova, Italy
c Atherosclerosis Research Unit, Istituto Scientifico S. Raffaele Hospital, University of Milan, Italy
d Istituto per l'Infanzia, Trieste, Italy

Correspondence to: Francisco E. Baralle.

Deficiency of lysosomal acid lipase (LAL) leads to either Wolman disease (WD) or the more benign cholesteryl ester storage disease (CESD). To identify the molecular basis of the different phenotypes we have characterised the LAL gene mutations in three new patients with LAL deficiency. A patient with WD was homozygote for a null allele Y303X. The other two patients, with CESD, presented either homozygosity for T267I or compound heterozygosity consisting of Q64R and an exon 8 donor splice site substitution (G'A in position -1). The mutants T267I and Q64R and the previously reported L273S, G66V, and H274Y CESD substitutions, overexpressed in stable clones, were found to be fully glycosylated and show an enzymatic activity of 3–8% of that of normal LAL. On the other hand, the {Delta}254–277 mutant protein derived from exon 8 skipping and the Y303X protein were totally inactive. By transient transfection of hybrid minigene constructs, the CESD G'A (-1) substitution resulted in partial exon inclusion, thus allowing the production of a small amount of normal LAL mRNA and hence of a functional enzyme. In contrast, a G'A substitution observed in WD at position +1 of the same exon 8 donor site resulted in complete exon skipping and the sole production of an inactive {Delta}254–277 protein.

In conclusion, LAL genotypes determine the level of residual enzymatic activity, thus explaining the severity of the phenotype.—Pagani, F., R. Pariyarath, R. Garcia, C. Stuani, A. B. Burlina, G. Ruotolo, M. Rabusin, and F. E. Baralle. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. J. Lipid Res. 1998. 39: 1382–1388.

Supplementary key words: alternative splicing, mutation, Wolman disease/etiology, recombinant proteins, phenotype


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Muntoni, H. Wiebusch, M. Jansen-Rust, S. Rust, U. Seedorf, H. Schulte, K. Berger, H. Funke, and G. Assmann
Prevalence of Cholesteryl Ester Storage Disease
Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1866 - 1868.
[Full Text] [PDF]


Home page
J BiochemHome page
O. Zschenker, T. Illies, and D. Ameis
Overexpression of lysosomal Acid lipase and other proteins in atherosclerosis.
J. Biochem., July 1, 2006; 140(1): 23 - 38.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Koffel, R. Tiwari, L. Falquet, and R. Schneiter
The Saccharomyces cerevisiae YLL012/YEH1, YLR020/YEH2, and TGL1 Genes Encode a Novel Family of Membrane-Anchored Lipases That Are Required for Steryl Ester Hydrolysis
Mol. Cell. Biol., March 1, 2005; 25(5): 1655 - 1668.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
O. Zschenker, C. Bahr, U.-F. Hess, and D. Ameis
Systematic Mutagenesis of Potential Glycosylation Sites of Lysosomal Acid Lipase
J. Biochem., March 1, 2005; 137(3): 387 - 394.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
O. Zschenker, N. Jung, J. Rethmeier, S. Trautwein, S. Hertel, M. Zeigler, and D. Ameis
Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease
J. Lipid Res., July 1, 2001; 42(7): 1033 - 1040.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
W. Wang, W. Li, Y. Ikeda, J.-I. Miyagawa, M. Taniguchi, E. Miyoshi, Y. Sheng, A. Ekuni, J. H. Ko, Y. Yamamoto, et al.
Ectopic expression of {{alpha}}1,6 fucosyltransferase in mice causes steatosis in the liver and kidney accompanied by a modification of lysosomal acid lipase
Glycobiology, February 1, 2001; 11(2): 165 - 174.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. Lohse, S. Maas, P. Lohse, M. Elleder, J. M. Kirk, G. T. N. Besley, and D. Seidel
Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease
J. Lipid Res., January 1, 2000; 41(1): 23 - 31.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
P. Lohse, S. Maas, P. Lohse, A. C. Sewell, O. P. van Diggelen, and D. Seidel
Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease
J. Lipid Res., February 1, 1999; 40(2): 221 - 228.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.